Clinical Trial Update: Food Effect Study of BMS-984923 in Healthy Older Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 food-effect study of the investigational compound BMS-984923 in healthy older volunteers, sponsored by Allyx Therapeutics, related to Alzheimer's diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease
• Dementia

Drugs mentioned

• BMS-984923

Snippet

Sponsor: Allyx Therapeutics | Conditions: Alzheimer Disease, Dementia | Phase 1 | Status: UNKNOWN